DuPont Decomposition

Why does MTEDUCARE earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

-94.0% = -58.8% × 0.16 × 9.88

Latest: FY2024

Profitability

Net Margin

-58.8%

-48.8% →-58.8%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.16x

0.16x →0.16x

Revenue per ₹ of assets

Leverage

Equity Multiplier

9.88x

2.83x →9.88x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 72.3 pp over 3 years. Driven by net margin declining (-48.8% → -58.8%), leverage rising (2.83x → 9.88x). High financial leverage (equity multiplier > 4x) amplifies returns but also risk.

Historical Decomposition

Last 3 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr-0Cr-48.8%0.162.83-21.7%
FY20230Cr-0Cr-105.0%0.205.18-106.8%
FY20240Cr-0Cr-58.8%0.169.88-94.0%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for MTEDUCARE

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

MTEDUCARE DuPont Analysis — ROE -94.0% | YieldIQ